T-Cell Re-Directing Therapy for the Treatment of Blood Cancer


At the conclusion of this activity, participants will be able to:

  1. Recognize the types of blood cancers that are most responsive to T-cell re-directing therapies.
  2. Explain the underlying principles and mechanisms of T-cell re-directing therapies.
  3. Discuss the latest research developments and future directions in T-cell re-directing therapies including emerging therapies and ongoing trials.